Sunshine Biopharma SBFM
NASDAQ SBFM
$0.79 0.00 (-0.33%)
As of: Sep 30, 2026 · 3:38 PM EDT

Sunshine Biopharma (SBFM) Other financing activities (2018 - 2019)

Updated

Sunshine Biopharma's Other financing activities came in at $7,590 for Q4 2019.

Analysis

Sunshine Biopharma (SBFM) Other financing activities (2018 - 2019) Analysis & Trends

Going back to Q1 2018, Sunshine Biopharma's Other financing activities data covers 4 quarters.

  • The Q4 2019 figure represents the highest quarterly Other financing activities since Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Sunshine Biopharma 1.08 Mn -38.01 Mn 2.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 7,590.00
Jun 30, 2019 -7,590.00
Sep 30, 2018 -72,534.00
Mar 31, 2018 72,534.00
API Access

Sunshine Biopharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=SBFM&period=max&api_key=YOUR_API_KEY